ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research

May 14, 1976

NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option

April 2, 1982